You are here

  • Home
  • Archive
  • Volume 72, Issue Suppl 3
  • SAT0261 Which Conventional DMARD to Select in the Treatment of Psoriatic Arthritis (PSA)? Data From Nor-Dmard on 1351 Treatment Courses with Methotrexate (MTX), Sulfasalazine (SSZ) And Leflunomide (LEF)

Citation Tools

Article menu
Download PDFPDF
Scientific Abstracts
Psoriatic arthritis
SAT0261 Which Conventional DMARD to Select in the Treatment of Psoriatic Arthritis (PSA)? Data From Nor-Dmard on 1351 Treatment Courses with Methotrexate (MTX), Sulfasalazine (SSZ) And Leflunomide (LEF)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Lie E, Fagerli KM, Rødevand E, et al
SAT0261 Which Conventional DMARD to Select in the Treatment of Psoriatic Arthritis (PSA)? Data From Nor-Dmard on 1351 Treatment Courses with Methotrexate (MTX), Sulfasalazine (SSZ) And Leflunomide (LEF)
Annals of the Rheumatic Diseases 2013;72:A670-A671.